DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

EyePoint Pharmaceuticals Q2 EPS $(0.1) Beats $(0.11) Estimate, Sales $8.6M Beat $7.8M Estimate

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.1) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share

Benzinga · 03/05/2020 12:19

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(0.1) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $8.6 million which beat the analyst consensus estimate of $7.8 million by 10.26 percent. This is a 1.06K percent increase over sales of $742 thousand the same period last year.